BASP1 is downregulated in several mammalian tumors including carcinoma, acute and chronic lymphocytic leukemia, and melanoma (Kaehler et al., 2015; Moribe et al., 2008; Ransohoff et al., 2017; Tchernitsa et al., 2004; Wang et al., 2004; Xu et al., 2015; Yeoh et al., 2002). Here, BASP1 is linked to melanoma.